What does CUSIP 64132R206 represent in this 13F holders report?

CUSIP 64132R206 is the security identifier for NRBO - NEUROBO PHARMACEUTICALS INC - COM NEW used to aggregate holder disclosures.

How many institutions held NRBO - NEUROBO PHARMACEUTICALS INC - COM NEW in Q3 2022?

5 institutional investors reported NRBO - NEUROBO PHARMACEUTICALS INC - COM NEW for Q3 2022. Use the holders table for investor-level position and value details.

NEUROBO PHARMACEUTICALS INC - COM NEW (NRBO)

CUSIP: 64132R206

Q3 2022 13F Holders as of 30 Sep 2022

Security type / class: Equity / COM NEW
Total 13F shares: 16,060
Total 13F value: $219,520
Share change: +16,022
SEC-reported price per share: $13.68
Number of holders: 5
Value change: +$219,000
Number of buys: 4

Security key

64132R206

Report period

Q3 2022

Institutions

Top holders

NRBO full security history Ownership snapshot Full 13F holder table MetaVia Inc. SEC filings MetaVia Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of NRBO - NEUROBO PHARMACEUTICALS INC - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

E&Investment, Inc.

Disclosed value leader

E&Investment, Inc.

Comparable rows

0/15

Latest evidence

26 Jul 2022

3/4/5 13F Highest disclosed value: $18,832,174 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

E&Investment, Inc. has the largest disclosed position value at $18.83M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens E&Investment, Inc.'s linked filing trail.

Disclosed position value Top 5

E&Investment, Inc. $18.83M

VANGUARD GROUP INC $237K

Murchinson Ltd. $98K

SUSQUEHANNA INTERNATIONAL GROUP, LLP $51K

SABBY MANAGEMENT, LLC $45K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
E&Investment, Inc.	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$18,832,174 6,016,669 shares	—	26 Jul 2022
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$237,000 493,995 shares	—	30 Jun 2022
Murchinson Ltd.	13F Company 13F	— denominator unverified	$98,000 205,256 shares	—	30 Jun 2022
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F Company 13F	— denominator unverified	$51,000 108,541 shares	—	30 Jun 2022
SABBY MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$45,000 93,376 shares	—	30 Jun 2022
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$30,000 65,290 shares	—	30 Jun 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

16,060

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

Q3 2022 holders

Holder diff

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 value	Q3 2022 value	Value change	Value Chg %